Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajashree Rana

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of the American Society of Nephrology : JASN|April 24, 2023
Tackling AKIRajashree Rana, Matthew D Breyer
The Journal of Biological Chemistry|September 11, 2016
Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) PepducinAndrew M Shearer, Rajashree Rana, Karyn Austin, et al.
Hepatology (Baltimore, Md.)|May 23, 2022
PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interferenceAndrew M Shearer, Yanling Wang, Elizabeth K Fletcher, et al.
The Journal of Biological Chemistry|May 3, 2015
Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor MimeticsPing Zhang, Andrew J Leger, James D Baleja, et al.
Nature Communications|December 20, 2013
Structural insights into the role of the Smoothened cysteine-rich domain in Hedgehog signallingRajashree Rana, Candace E Carroll, Ho-Jin Lee, et al.
Molecular Metabolism|November 1, 2019
PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver diseaseRajashree Rana, Andrew M Shearer, Elizabeth K Fletcher, et al.
Physiological Reports|September 26, 2024
VEPTP inhibition with an extracellular domain targeting antibody did not restore albuminuria in a mouse model of diabetic kidney diseaseRajashree Rana, Thomas A Natoli, Puneet Khandelwal, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 7, 2018
Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of AtherosclerosisRajashree Rana, Tianfang Huang, Georgios Koukos, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of the American Society of Nephrology : JASN|April 24, 2023
Tackling AKIRajashree Rana, Matthew D Breyer
The Journal of Biological Chemistry|September 11, 2016
Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) PepducinAndrew M Shearer, Rajashree Rana, Karyn Austin, et al.
Hepatology (Baltimore, Md.)|May 23, 2022
PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interferenceAndrew M Shearer, Yanling Wang, Elizabeth K Fletcher, et al.
The Journal of Biological Chemistry|May 3, 2015
Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor MimeticsPing Zhang, Andrew J Leger, James D Baleja, et al.
Nature Communications|December 20, 2013
Structural insights into the role of the Smoothened cysteine-rich domain in Hedgehog signallingRajashree Rana, Candace E Carroll, Ho-Jin Lee, et al.
Molecular Metabolism|November 1, 2019
PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver diseaseRajashree Rana, Andrew M Shearer, Elizabeth K Fletcher, et al.
Physiological Reports|September 26, 2024
VEPTP inhibition with an extracellular domain targeting antibody did not restore albuminuria in a mouse model of diabetic kidney diseaseRajashree Rana, Thomas A Natoli, Puneet Khandelwal, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 7, 2018
Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of AtherosclerosisRajashree Rana, Tianfang Huang, Georgios Koukos, et al.
Pageof 1